A carregar...

New cast for a new era: preclinical cancer drug development revisited

Molecularly targeted agents promise to revolutionize therapeutics by reducing morbidity and mortality in patients with cancer. However, despite an urgent need for more effective anticancer compounds, current preclinical drug evaluations largely fail to satisfy the demand. New preclinical strategies,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Herter-Sprie, Grit S., Kung, Andrew L., Wong, Kwok-Kin
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3754257/
https://ncbi.nlm.nih.gov/pubmed/23999436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI68340
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!